Intestinal Akkermansia muciniphila predicts clinical response to PD-1 blockade in patients with advanced non-small-cell lung cancer

Cited by (689)

Items 201–300 of 689

1. YTHDF1 Attenuates TBI-Induced Brain-Gut Axis Dysfunction in Mice
   Peizan Huang, Min Liu, Jing Zhang, Xiang Zhong, Chunlong Zhong · 2023 · International Journal of Molecular Sciences
2. The DAV132 colon-targeted adsorbent does not interfere with plasma concentrations of antibiotics but prevents antibiotic-related dysbiosis: a randomized phase I trial in healthy volunteers
   Messaoudene, Meriem, Ferreira, Stéphanie, Saint-Lu, Nathalie, Ponce, Mayra, Truntzer, Caroline, Boidot, Romain, Le Bescop, Clément, Loppinet, Thomas, Corbel, Tanguy, Féger, Céline et al. · 2024 · Nature Communications
3. The Complex Role of the Microbiome in Non-Small Cell Lung Cancer Development and Progression
   Vanessa G. P. Souza, Aisling Forder, Michelle E. Pewarchuk, Nikita Telkar, Rachel Paes de Araújo, Greg L. Stewart, Juliana Vieira, Patrícia P. Reis, Wan L. Lam · 2023 · Cells
4. Gut microbiota and clinical response to immune checkpoint inhibitor therapy in patients with advanced cancer
   John Wen‐Cheng Chang, Jia‐Juan Hsieh, Chih-Yu Tsai, Horng-Yih Chiu, Yu-Feng Lin, Chiao‐En Wu, Yung‐Chi Shen, Ming‐Mo Hou, Chieh-Ying Chang, Jian-An Chen et al. · 2024 · Biomedical Journal
5. Salivary Microbiome Relates to Neoadjuvant Immunotherapy Response in OSCC
   Xi Wang, Y.T. Liu, Jian‐Gang Ren, H.M. Liu, Q. Fu, Yi Yang, Q.Y. Fu, Gang Chen · 2024 · Journal of Dental Research
6. Eravacycline improves the efficacy of anti-PD1 immunotherapy via AP1/CCL5 mediated M1 macrophage polarization in melanoma
   Nian Liu, Mingjie Yan, Can Lü, Qian Tao, Jie Wu, Zhaokai Zhou, Jing Chen, Xiang Chen, Cong Peng · 2024 · Biomaterials
7. Understanding the role of the gut microbiome in solid tumor responses to immune checkpoint inhibitors for personalized therapeutic strategies: a review
   Mi Young Lim, Seungpyo Hong, Young‐Do Nam · 2025 · Frontiers in Immunology
8. Recent advances in biomarkers for predicting the efficacy of immunotherapy in non-small cell lung cancer
   Jiacheng Zhang, Zehao Song, Yuanjie Zhang, Chentong Zhang, Qi Xue, Guochao Zhang, Fengwei Tan · 2025 · Frontiers in Immunology
9. New insights into gut microbiota–prostate cancer crosstalk
   Jalal Laaraj, Gabriel Lachance, Alain Bergeron, Yves Fradet, Karine Robitaille, Vincent Fradet · 2025 · Trends in Molecular Medicine
10. Gut dysbiosis in cancer immunotherapy: microbiota-mediated resistance and emerging treatments
    Liza Eiman, Khadija Moazzam, Sumaira Anjum, Humera Kausar, Elham Abdullatif M. Sharif, Wisam Nabeel Ibrahim · 2025 · Frontiers in Immunology
11. Polydatin alleviates bleomycin‐induced pulmonary fibrosis and alters the gut microbiota in a mouse model
    Jia Yang, Xiawei Shi, Rundi Gao, Liming Fan, Ruilin Chen, Yu Cao, Tingzhen Xu, Junchao Yang · 2023 · Journal of Cellular and Molecular Medicine
12. Biomarker-Driven Personalization of Neoadjuvant Immunotherapy in Melanoma
    Lotte L. Hoeijmakers, Irene L. M. Reijers, Christian U. Blank · 2023 · Cancer Discovery
13. Modulation of gut microbiota: a novel approach to enhancing the effects of immune checkpoint inhibitors
    Jinglong Huang, Caifeng Gong, Aiping Zhou · 2023 · Therapeutic Advances in Medical Oncology
14. Targeted modulation of gut and intra-tumor microbiota to improve the quality of immune checkpoint inhibitor responses
    WeiZhou Wang, Junying Fan, Chi Zhang, Yuan Huang, Yue Chen, Shaozhi Fu, Jingbo Wu · 2024 · Microbiological Research
15. Gut Microbiota–Related Biomarkers in Immuno-Oncology
    Silva, Carolina Alves Costa, Fidelle, Marine, Almonte, Andrew A., Derosa, Lisa, Zitvogel, Laurence · 2025 · Annual Review of Pharmacology and Toxicology
16. Untangling the web of intratumor microbiota in lung cancer
    Weici Laurence Liu, Jingtong Xu, Zheshun Pi, Yundi Chen, Guanyu Jiang, Yuan Wan, Wenjun Mao · 2023 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
17. Astaxanthin exerts an adjunctive anti-cancer effect through the modulation of gut microbiota and mucosal immunity
    Pengfei Ren, Han Yue, Qingjuan Tang, Yuming Wang, Changhu Xue · 2024 · International Immunopharmacology
18. The implication of microbiome in lungs cancer: mechanisms and strategies of cancer growth, diagnosis and therapy
    Yasmin Bano, Abhinav Shrivastava, Piyush Kumar Shukla, Anis Ahmad Chaudhary, Salah-Ud-Din Khan, Shahanavaj Khan · 2024 · Critical Reviews in Microbiology
19. Akkermansia muciniphila in the small intestine improves liver fibrosis in a murine liver cirrhosis model
    Noriaki Oguri, Jun Miyoshi, Yuu Nishinarita, Haruka Wada, Nobuki Nemoto, Noritaka Hibi, Naohiro Kawamura, Sawako Miyoshi, Sonny T. M. Lee, Minoru Matsuura et al. · 2024 · npj Biofilms and Microbiomes
20. The interplay between gut microbiota, antibiotics, and immune checkpoint inhibitors in patients with cancer: A narrative review with biological and clinical aspects
    Demi Wekking, Carolina Alves Costa Silva, Roberto Viscò, Nerina Denaro, Matteo Lambertini, Antonio Maccioni, Erica Loddo, Karen E Willard-Gallo, Mario Scartozzi, Lisa Derosa et al. · 2025 · Critical Reviews in Oncology/Hematology
21. Advances and mechanisms of gut microbiota modulation in enhancing immune checkpoint inhibitor efficacy
    Liqiao Chen, Baoyi Li, Menghang Zu, Rui Luís Reis, Subhas Chandra Kundu, Bo Xiao · 2025 · Seminars in Cancer Biology
22. Dynamic gut microbiota changes in patients with advanced malignancies experiencing secondary resistance to immune checkpoint inhibitors and immune-related adverse events
    Yanlin Zeng, Qingya Shi, Xinyu Liu, Hao Thi Tang, Bo Lu, Qingyang Zhou, Yan Xu, Minjiang Chen, Jing Zhao, Yue Li et al. · 2023 · Frontiers in Oncology
23. Metabolites analysis of plantamajoside based on gut microbiota-drug interaction
    Hui Min Xu, Hang Yu, Jie Fu, Zhengwei Zhang, Jia-Chun Hu, Jin‐Yue Lu, Xinyu Yang, Meng-Meng Bu, Jian‐Dong Jiang, Yan Wang · 2023 · Phytomedicine
24. Microbiome and lung cancer: carcinogenic mechanisms, early cancer diagnosis, and promising microbial therapies
    Weici Laurence Liu, Zheshun Pi, Xiaokun Wang, Chenwei Shang, Chenghu Song, Ruixin Wang, Zhao He, Xu Zhang, Yuan Wan, Wenjun Mao · 2024 · Critical Reviews in Oncology/Hematology
25. Gut microbiota and immunosenescence in cancer
    Yaozheng Xu, Chuan He, Ying Xi, Yue Zhang, Yibo Bai · 2024 · Seminars in Cancer Biology
26. Impact of the ONCOBIOME network in cancer microbiome research
    Zitvogel, Laurence, Derosa, Lisa, Routy, Bertrand, Loibl, Sibylle, Heinzerling, Lucie, de Vries, I. Jolanda M., Engstrand, Lars, ONCOBIOME Network, Silva, Carolina Alves Costa, Barbieri, Daniela et al. · 2025 · Nature Medicine
27. Surrogate markers of intestinal dysfunction associated with survival in advanced cancers
    Birebent, Roxanne, Drubay, Damien, Alves Costa Silva, Carolina, Marmorino, Federica, Vitali, Giacomo, Piccinno, Gianmarco, Hurtado, Yoan, Bonato, Adele, Belluomini, Lorenzo, Messaoudene, Meriem et al. · 2025 · OncoImmunology
28. Pangenomic analysis identifies correlations between Akkermansia species and subspecies and human health outcomes
    Katherine D. Mueller, Maria Emilia Panzetta, Lauren E. Davey, Jessica R. McCann, John Franklin Rawls, Gilberto E. Flores, Raphael H. Valdivia · 2024 · Microbiome Research Reports
29. Navigating the complex relationship between human gut microbiota and breast cancer: Physiopathological, prognostic and therapeutic implications
    Francesco Schettini, Federica Gattazzo, Sabrina Nucera, Elisa Rubio-García, Rubén López-Aladid, Lorenzo Morelli, Alessandra Fontana, Paolo Giovanni Vigneri, Climent Casals‐Pascual, Valerio Iebba et al. · 2024 · Cancer Treatment Reviews
30. Looking Beyond Checkpoint Inhibitor Monotherapy: Uncovering New Frontiers for Pancreatic Cancer Immunotherapy
    Eileena F. Giurini, Oliver G. Ralph, Sam G. Pappas, Kajal H. Gupta · 2024 · Molecular Cancer Therapeutics
31. Assessing the impact of probiotics on immunotherapy effectiveness and antibiotic-mediated resistance in cancer: a systematic review and meta-analysis
    Shuya Zhao, Zian Lu, Fangmin Zhao, Shihuan Tang, Lishan Zhang, Cuiling Feng · 2025 · Frontiers in Immunology
32. Harnessing the microbiome for cancer therapy
    Roy Hajjar, Ruben A. T. Mars, Purna Kashyap · 2026 · Nature Reviews Microbiology
33. Microbiome modulation of tumorigenesis and immune responses
    Yuning Chen, Ying Fang, Zibai Lyu, Yanxin Tian, Siyue Niu, Yan-Ruide Li, Lili Yang · 2026 · Journal of Biomedical Science
34. Gut Microbiota, the Potential Biological Medicine for Prevention, Intervention and Drug Sensitization to Fight Diseases
    Haijie Wu, Xiaoguang Chen, Sen Zhang, Jiaxin Li · 2022 · Nutrients
35. The negative impact of opioids on cancer patients treated with immune checkpoint inhibitors: a systematic review and meta-analysis
    Mingguang Ju, Ziming Gao, Xiaofang Liu, Heng Zhou, Ruiying Wang, Chen Zheng, Daosong Dong, Zhi Zhu, Kai Li · 2022 · Journal of Cancer Research and Clinical Oncology
36. The lung, the niche, and the microbe: Exploring the lung microbiome in cancer and immunity
    Mai Huynh, Meredith J. Crane, Amanda Mercedes Jamieson · 2023 · Frontiers in Immunology
37. Impact of microbiota on breast cancer hormone therapy
    Safae Aarab Terrisse, Laurence Zitvogel, Guido Kroemer · 2023 · Cell Stress
38. Gut microbiome predicts gastrointestinal toxicity outcomes from chemoradiation therapy in patients with head and neck squamous cell carcinoma
    Cecilia Hes, Antoine Desîlets, Marion Tonneau, Omar El Ouarzadi, Marina De Figueiredo Sousa, Houda Bahig, Édith Filion, Phuc Félix Nguyen‐Tan, Apostolos Christopoulos, Myriam Benlaïfaoui et al. · 2023 · Oral Oncology
39. Harnessing Bacterial Extracellular Vesicle Immune Effects for Cancer Therapy
    İrem Karaman, Asmita Pathak, Defne Bayık, Dionysios Christos Watson · 2024 · Pathogens and Immunity
40. Gut microbiota alteration - Cancer relationships and synbiotic roles in cancer therapies
    Adekunle Babajide Rowaiye, Gordon C. Ibeanu, Doofan Bur, Sandra Nnadi, Odinaka E. Mgbeke, Ugonna Chinwe Morikwe · 2024 · The Microbe
41. Causal role of the gut microbiome in certain human diseases: a narrative review
    Connor J. Prosty, Khaled Katergi, Jesse Papenburg, Alexander Lawandi, Todd Campbell Lee, Hao Shi, Philip Burnham, Lee R. Swem, Bertrand Routy, Cédric P. Yansouni et al. · 2024 · eGastroenterology
42. Interaction Between Microbiota and Immunity: Molecular Mechanisms, Biological Functions, Diseases, and New Therapeutic Opportunities
    Jingjing Zeng, Zhili He, Guoqing Wang, Yuxin Ma, Feng Zhang · 2025 · MedComm
43. Gut and urinary microbiota: the causes and potential treatment measures of renal cell carcinoma
    Jian-wei Yang, Shun Wan, Kunpeng Li, Siyu Chen, Li Yang · 2023 · Frontiers in Immunology
44. Revisiting Coley’s Toxins: Immunogenic Cardiolipins from Streptococcus pyogenes
    Yern‐Hyerk Shin, Sunghee Bang, Sung‐Moo Park, Xiao Ma, Chelsi D. Cassilly, Daniel B. Graham, Ramnik J. Xavier, Jon Clardy · 2023 · Journal of the American Chemical Society
45. Impact of antibiotics, corticosteroids, and microbiota on immunotherapy efficacy in patients with non-small cell lung cancer
    Maria Eduarda Simmer Zapata, Alba Moratiel Pellitero, Dolores Isla, Eva Heredero Gálvez, Marta Gascón Ruiz, Andrea Sesma, Raquel Barbero-Herranz, Javier Galeano, Rosa del Campo, Maitane Ocáriz et al. · 2024 · Heliyon
46. Role of gut microbiome in suppression of cancers
    Yao Xu, Zhaoyu Gao, Jiaying Liu, Qian‐Qian Yang, Shunjiang Xu · 2025 · Gut Microbes
47. Microbiota-centered interventions to boost immune checkpoint blockade therapies
    Almonte, Andrew A., Thomas, Simon, Zitvogel, Laurence · 2025 · Journal of Experimental Medicine
48. Gut microbial predictors of first-line immunotherapy efficacy in advanced NSCLC patients
    Anna Grenda, Ewelina Iwan, Barbara Kuźnar-Kamińska, Arkadiusz Bomba, Katarzyna Bielińska, Paweł Krawczyk, Izabela Chmielewska, Małgorzata Frąk, Michał Szczyrek, Anna Rolska-Kopińska et al. · 2025 · Scientific Reports
49. Interaction between gut microbiota and T cell immunity in colorectal cancer
    Zhuang Jing, Yinhang Wu, Jian Chu, Qu Zhanbo, Xinyue Wu, Shuwen Han · 2025 · Autoimmunity Reviews
50. Intestinal and esophageal microbiota in esophageal cancer development and treatment
    Yuta Baba, Kohei Tajima, Kiyoshi Yoshimura · 2025 · Gut Microbes
51. Immune checkpoint inhibitors and immunosuppressive tumor microenvironment: current challenges and strategies to overcome resistance
    Gurpreet Singh Gill, Simmi Kharb, Gitanjali Goyal, Prasenjit Das, Kailash Chand Kurdia, Ruby Dhar, Subhradip Karmakar · 2025 · Immunopharmacology and Immunotoxicology
52. Pharmacomicrobiomics
    Naomi Gronich, Naama Geva‐Zatorsky, Rachel Herren, Libusha Kelly, Ziv Cohen, Haiying Zhou, Y.H. Chen, Khalid Shah, Talin A. Robinson‐Catala, Grecia Frisby et al. · 2025 · Clinical Pharmacology & Therapeutics
53. Tissue-resident microbiota impacts colorectal cancer progression and prognosis
    Zhun Shi, Huahui Ren, Cong Lin, Fuqiang Li, Meizhen Wu, Fangming Yang, Tian Luo, Luís Nunes, Anders Isaksson, Klara Hammarström et al. · 2025 · Nature Communications
54. Artificial intelligence–enabled multi-omics biomarkers for immune checkpoint blockade: mechanisms, predictive modeling, and clinical translation
    Xiaodong Wang, Di Xiong, Songli Cui, Bingchen Duan, Gouping Ding, Yiping Huang, Qianqian Wang · 2026 · Frontiers in Immunology
55. Gut microbiota: a potential target for improved cancer therapy
    Mingkuan Zhao, Gen Jiang, Hu Zhou, Jiaqi Li, Wei Xiang, Shenjie Li, Haorun Wang, Jie Zhou · 2022 · Journal of Cancer Research and Clinical Oncology
56. Immune Checkpoint Inhibitors and the Exposome: Host-Extrinsic Factors Determine Response, Survival, and Toxicity
    Elio Gregory Pizzutilo, Rebecca Romanò, Laura Roazzi, Alberto Giuseppe Agostara, Sara Oresti, Annalisa Zeppellini, Laura Giuseppina Giannetta, Giulio Cerea, Diego Signorelli, Salvatore Siena et al. · 2023 · Cancer Research
57. Bifidobacterium in anticancer immunochemotherapy: friend or foe?
    Giorgia Procaccianti, Sara Roggiani, Gabriele Conti, Patrizia Brigidi, Silvia Turroni, Federica D’Amico · 2023 · Microbiome Research Reports
58. The role of extratumoral and intratumoral microorganisms in cancer immunotherapy
    Yurong Du, Lei Liu, Wang Ma, Weiliang Yan, Wenhao Mao, Yabing Du, Kang Cui, Yu Pu, Zhen Li, Philippe Jean Sansonetti et al. · 2023 · The Innovation Life
59. Exploring the human microbiome – A step forward for precision medicine in breast cancer
    Asmita Jotshi, Krishna Kishore Sukla, Mohammed Monzoorul Haque, Chandrani Bose, Binuja Varma, Chaitanyanand B. Koppiker, Sneha Joshi, Rupa Mishra · 2023 · Cancer Reports
60. Gut microbiota and metabolites associated with immunotherapy efficacy in extensive-stage small cell lung cancer: a pilot study
    Li‐Yang Sun, Xueting Wang, Huimin Zhou, Rui Li, Ming Meng, Giandomenico Roviello, Byeongsang Oh, Lingxin Feng, Zhuang Yu, Jing Wang · 2024 · Journal of Thoracic Disease
61. Gut Microbiota in Advanced NSCLC Receiving Chemoimmunotherapy: An Ancillary Biomarker Study From the Phase III Trial JCOG2007 (NIPPON)
    Taiki Hakozaki, Kentaro Tanaka, Yoshimasa Shiraishi, Yuta Sekino, Noriko Mitome, Yusuke Okuma, Tomoiki Aiba, Takahiro Utsumi, Junko Tanizaki, Koichi Azuma et al. · 2025 · Journal of Thoracic Oncology
62. Optimizing anti-PD-1/PD-L1 therapy efficacy and fecal microbiota transplantation donor selection through gut mycobiome-based enterotype
    Muni Hu, Xiaoqiang Zhu, Xiaowen Huang, Hua Li, Xiaolin Lin, Hangyu Zhang, Ye Hu, Tianying Tong, Lingxi Li, Baoqin Xuan et al. · 2025 · Cell Reports
63. Nutrient acquisition of gut microbiota: Implications for tumor immunity
    Yusha Wang, Jing Huang, Huan Tong, Yuting Jiang, Jiang Yu, Xuelei Ma · 2025 · Seminars in Cancer Biology
64. Broad-spectrum antibiotics associated gut microbiome disturbance impairs T cell immunity and promotes lung cancer metastasis: a retrospective study
    Ke Xu, Jixu Cai, Jun Qiao Xing, Xu Li, Beishou Wu, Zhuxian Zhu, Ziqiang Zhang · 2022 · BMC Cancer
65. Zengshengping improves lung cancer by regulating the intestinal barrier and intestinal microbiota
    E. Sun, Xiangqi Meng, Zhaoxia Kang, Huimin Gu, Mingyu Li, Xiaobin Tan, Liang Feng, Xiao‐Bin Jia · 2023 · Frontiers in Pharmacology
66. Fecal Microbiota Transplantation as a Cancer Therapeutic
    Ronen Stoff, Yochai Wolf, Ben Boursi · 2023 · The Cancer Journal
67. Depicting the landscape of gut microbial-metabolic interaction and microbial-host immune heterogeneity in deficient and proficient DNA mismatch repair colorectal cancers
    Jinming Li, Yangyang Guo, Jianqiang Liu, Fanying Guo, Lutao Du, Yongzhi Peter Yang, Xinxiang Li, Yanlei Ma · 2023 · Journal for ImmunoTherapy of Cancer
68. Candida albicans overgrowth disrupts the gut microbiota in mice bearing oral cancer
    Xu Wang, Shuangshaung Wu, Linman Li, Zhimin Yan · 2023 · Mycology&#58 An International Journal on Fungal Biology
69. The gut microbiome modulate response to immunotherapy in cancer
    Shanshan Jiang, Zi‐Ran Kang, Yingxuan Chen, Jing‐Yuan Fang · 2024 · Science China Life Sciences
70. ‘Know thyself’ – host factors influencing cancer response to immune checkpoint inhibitors
    Ashray Gunjur, Andrea Manrique-Rincón, Oliver Klein, Andreas Behren, Trevor D. Lawley, Sarah Joanne Welsh, David J. Adams · 2022 · The Journal of Pathology
71. Scalable log-ratio lasso regression for enhanced microbial feature selection with FLORAL
    Teng Fei, Tyler Funnell, Nicholas R. Waters, Sandeep S. Raj, Mirae Baichoo, Keimya D. Sadeghi, Anqi Dai, Oriana Miltiadous, Roni Shouval, Meng Lv et al. · 2024 · Cell Reports Methods
72. Recent advances of machine learning applications in human gut microbiota study: from observational analysis toward causal inference and clinical intervention
    Felix Salim, Sayaka Mizutani, Moreno Zolfo, Takuji Yamada · 2023 · Current Opinion in Biotechnology
73. Comedications with Immune Checkpoint Inhibitors: Involvement of the Microbiota, Impact on Efficacy and Practical Implications
    Julien Colard‐Thomas, Quentin Dominique Thomas, Marie Viala · 2023 · Cancers
74. Combination of multiple omics techniques for a personalized therapy or treatment selection
    Chiara Massa, Barbara Seliger · 2023 · Frontiers in Immunology
75. Gut microbiota and immunotherapy of renal cell carcinoma
    Stefano Bibbò, Serena Porcari, Livio Enrico Del Vecchio, Andrea Severino, Benjamin Harvey Mullish, Gianluca Ianiro, Antonio Gasbarrini, Giovanni Cammarota · 2023 · Human Vaccines & Immunotherapeutics
76. Metabolic heterogeneity in tumor microenvironment – A novel landmark for immunotherapy
    Chen Chen, Peng Han, Yanping Qing · 2024 · Autoimmunity Reviews
77. Schizophyllum commune fruiting body polysaccharides inhibit glioma by mediating ARHI regulation of PI3K/AKT signalling pathway
    Shi-Xing Zheng, Jian-Ping Chen, Ri-Sheng Liang, Bing-Bo Zhuang, Chunhua Wang, Guoliang Zhang, Song‐sheng Shi, Jing Chen · 2024 · International Journal of Biological Macromolecules
78. The Gut Microbiome as a Biomarker and Therapeutic Target of Immune Checkpoint Inhibitors: A Review for Oncologists
    Thiti Susiriwatananont, Panuch Eiamprapaporn, Maria Vazquez Roque, Francis A. Farraye, Adam Pearlman, Saranya Chumsri · 2025 · Cells
79. Too much water drowned the miller: Akkermansia determines immunotherapy responses
    Le Li, Florencia M. McAllister · 2022 · Cell Reports Medicine
80. Pathogenesis of Tobacco-Associated Lung Adenocarcinoma Is Closely Coupled with Changes in the Gut and Lung Microbiomes
    Casey T. Finnicum, Zahraa Rahal, Maya Hassane, Warapen Treekitkarnmongkol, Ansam F. Sinjab, Rhiannon Morris, Yuejiang Liu, Elizabeth Tang, Sarah Viet, Jason L. Petersen et al. · 2022 · International Journal of Molecular Sciences
81. Fluctuations in Gut Microbiome Composition During Immune Checkpoint Inhibitor Therapy
    Joy Sarkar, Eduardo Cortes Gomez, Takaaki Oba, Hongbin Chen, Grace Kho Dy, Brahm H. Segal, Marc S. Ernstoff, Fumito Ito · 2023 · World Journal of Oncology
82. Complementarity between Microbiome and Immunity May Account for the Potentiating Effect of Quercetin on the Antitumor Action of Cyclophosphamide in a Triple-Negative Breast Cancer Model
    Andrea Manni, Yuan‐Wan Sun, Todd D. Schell, Tymofiy Lutsiv, Henry J. Thompson, Kun-Ming Chen, Cesar A. Aliaga, Junjia Zhu, Karam El‐Bayoumy · 2023 · Pharmaceuticals
83. Biomarkers of Immunotherapy Response in Patients with Non-Small-Cell Lung Cancer: Microbiota Composition, Short-Chain Fatty Acids, and Intestinal Permeability
    Alba Moratiel Pellitero, Maria Eduarda Simmer Zapata, Marta Gascón Ruiz, Andrea Sesma, Elisa Quílez, Ariel Ramírez-Labrada, Luis Martínez‐Lostao, María Pilar Domingo, Patricia Esteban, Alfonso Yubero et al. · 2024 · Cancers
84. Correlation of distribution characteristics and dynamic changes of gut microbiota with the efficacy of immunotherapy in EGFR-mutated non-small cell lung cancer
    Wei‐Chi Luo, Shi‐Qi Mei, Zijian Huang, Zhihong Chen, Yichen Zhang, Mingyi Yang, Jiaqi Liu, Jingyan Xu, Xiaorong Yang, Ri-Wei Zhong et al. · 2024 · Journal of Translational Medicine
85. Bronchoalveolar Lavage Fluid Microbiota is Associated with the Diagnosis and Prognosis Evaluation of Lung Cancer
    Chen Cheng, Zhifeng Wang, Chao Ding, P. Liu, Xiaoqiang Xu, Yan Li, Yi Yan, X. Yin, Bi Chen, Bing Gu · 2024 · Phenomics
86. Impact of the Lung Microbiota on Development and Progression of Lung Cancer
    Amine Belaïd, Barnabé Roméo, Guylène Rignol, Jonathan Benzaquen, Tanguy Audoin, Valérie Vouret‐Craviari, Patrick Brest, Raphaëlle Varraso, Martin von Bergen�, Charles‐Hugo Marquette et al. · 2024 · Cancers
87. Dietary pattern and the corresponding gut microbiome in response to immunotherapy in Thai patients with advanced non-small cell lung cancer (NSCLC)
    Piyada Sitthideatphaiboon, Nicha Somlaw, Nicha Zungsontiporn, Pongsakorn Ouwongprayoon, Narittee Sukswai, Krittiya Korphaisarn, Naravat Poungvarin, Chatchawit Aporntewan, Nattiya Hirankarn, Chanida Vinayanuwattikun et al. · 2024 · Scientific Reports
88. The beneficial effects of Akkermansia muciniphila and its derivatives on pulmonary fibrosis
    Shahrbanoo Keshavarz Azizi Raftar, Romina Bahrami, Danial Hashemi, Arefeh Shahryari, Amitis Ramezani, Fatemeh Ashrafian, Seyed Davar Siadat · 2024 · Biomedicine & Pharmacotherapy
89. Enriched pathways in gut microbiome predict response to immune checkpoint inhibitor treatment across demographic regions and various cancer types
    Xunhui Cai, Jennifer Y. Cho, Lijun Chen, Yufeng Liu, Fenghu Ji, K. Salgado, Si-Yi Ge, De-Hua Yang, Huijuan Yu, J. Shao et al. · 2025 · iScience
90. Therapeutic potential of fecal microbiota transplantation in colorectal cancer based on gut microbiota regulation: from pathogenesis to efficacy
    Chen Gu, Gengyu Sha, Binbin Zeng, Herong Cao, Yibo Cao, Dong Tang · 2025 · Therapeutic Advances in Gastroenterology
91. Changes of gut microbiota structure in rats infected with Toxoplasma gondii
    Qingbo Lv, He Ma, Jiaqi Wei, Yifeng Qin, Hong‐Yu Qiu, Hong‐Bo Ni, Lihua Yang, Hongwei Cao · 2022 · Frontiers in Cellular and Infection Microbiology
92. Gut microbiota composition is associated with the efficacy of Delta-24-RGDOX in malignant gliomas
    Natalie M. Meléndez-Vázquez, Teresa T. Nguyen, Xuejun Fan, Andres R. Lopez-Rivas, Juan Fueyo-Margareto, Candelaria Gomez‐Manzano, Filipa Godoy‐Vitorino · 2024 · Molecular Therapy Oncology
93. Mucosal microbiota characterization in gastric cancer identifies immune-activated–related transcripts relevant gastric microbiome signatures
    Chengjia Qian, Hui Jiang, Ziyao Peng, Xiaoyan Sun, Jiali Zhang · 2024 · Frontiers in Immunology
94. Novel Strategies for the Treatment of Lung Cancer: An In-depth Analysis of the Use of Immunotherapy, Precision Medicine, and Artificial Intelligence to Improve Prognoses
    Pawan Kedar, Sankha Bhattacharya, Abhishek Kanugo, Bhupendra Gopalbhai Prajapati · 2025 · Current Medicinal Chemistry
95. Nivolumab plus low-dose ipilimumab in hypermutated HER2-negative metastatic breast cancer: a phase II trial (NIMBUS)
    Romualdo Barroso‐Sousa, Jorge Gómez Tejeda Zañudo, Tianyu Li, Sangeetha Meda Reddy, Leisha A. Emens, Thomas M. Kuntz, Carolina Alves Costa Silva, Saud H. AlDubayan, Hoyin Chu, Beth A. Overmoyer et al. · 2025 · Nature Communications
96. Oral Microalgae‐Based Biosystem to Enhance Irreversible Electroporation Immunotherapy in Hepatocellular Carcinoma
    Cheng Zeng, Shiyuan Hua, Jiayu Zhou, Tangye Zeng, Jianke Chen, Lijian Su, Angfeng Jiang, Min Zhou, Zhe Tang · 2025 · Advanced Science
97. Akkermansia muciniphila extracellular vesicles: Function and theranostic potential in disease
    Yu-di Wang, Wenlong Lin, Shaohuan Wu, Xiaojing He, Zihao Ou, Lei Zheng · 2025 · LabMed discovery.
98. The multi-kingdom cancer microbiome
    Anders B. Dohlman, Xiangyu Pan, Laurence Zitvogel, Iliyan Dimitrov Iliev · 2025 · Nature Microbiology
99. A review on microbiota: relation with diseases and nutrients role
    Emel Öz, Ayşegül Şimşek, Melih Şimşek, Nihal Tuncer, Muharrem Bayrak, Kenan Çadırcı, Charles Stephen Brennan, Mukul Kumar, Charalampos Proestos, Margaret Anne Brennan et al. · 2023 · International Journal of Food Science & Technology
100. mEnrich-seq: methylation-guided enrichment sequencing of bacterial taxa of interest from microbiome
     Lei Cao, Yimeng Kong, Yu Fan, Mi Ni, Alan Tourancheau, Magdalena Ksiezarek, Edward A. Mead, Tonny Koo, Melissa Gitman, Xue‐Song Zhang et al. · 2024 · Nature Methods